Bank Of Montreal Vericel Corp Transaction History

Bank Of Montreal

$192 Billion
Q1 2025

A detailed history of Bank Of Montreal transactions in Vericel Corp stock. As of the latest transaction made, Bank Of Montreal holds 7,805 shares of VCEL stock, worth $338,268. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,805

Previous 6,217 25.54%

Holding current value

$338,268

Previous $341,000 2.05%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$44.5 - $61.8 $70,666 - $98,138	1,588 Added 25.54%	7,805 $348,000
Q4 2024 Feb 13, 2025	BUY	$40.05 - $59.11 $36,805 - $54,322	919 Added 17.35%	6,217 $341,000
Q3 2024 Nov 13, 2024	SELL	$42.25 - $53.56 $4,985 - $6,320	-118 Reduced 2.18%	5,298 $223,000
Q2 2024 Aug 14, 2024	BUY	$41.71 - $52.9 $5,797 - $7,353	139 Added 2.63%	5,416 $248,000
Q1 2024 May 13, 2024	BUY	$32.52 - $52.33 $171,608 - $276,145	5,277 New	5,277 $274,000
Q1 2023 Jun 13, 2024	BUY	$23.85 - $31.34 $41,379 - $54,374	1,735 Added 32.88%	7,012 $205,000
Q2 2022 Aug 11, 2022	SELL	$22.88 - $39.45 $135,403 - $233,465	-5,918 Reduced 41.4%	8,375 $215,000
Q1 2022 May 12, 2022	SELL	$31.69 - $43.29 $6,464 - $8,831	-204 Reduced 1.41%	14,293 $562,000
Q4 2021 Feb 11, 2022	SELL	$35.2 - $52.6 $13.2 Million - $19.8 Million	-376,150 Reduced 96.29%	14,497 $596,000
Q3 2021 Nov 12, 2021	SELL	$46.35 - $59.75 $1.05 Million - $1.35 Million	-22,643 Reduced 5.48%	390,647 $19.1 Million
Q2 2021 Aug 12, 2021	BUY	$47.2 - $67.81 $19.5 Million - $28 Million	413,290 New	413,290 $23.9 Million

Others Institutions Holding VCEL

# of Institutions

291

Shares Held

52.1M

Call Options Held

36.7K

Put Options Held

6.4K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.04B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account